Vascular Dementia Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Vascular Dementia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Predictors of Emergency Department Use in Frail Patients

ElderlyFrailtyAlzheimer s Disease+3 more
University of Pisa110 enrolled1 locationNCT07259499
Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

DementiaAlzheimer DiseaseParkinson Disease+7 more
University Health Network, Toronto500 enrolled4 locationsNCT06529744
Recruiting
Not Applicable

The BRAIN App (Phase 2 SBIR)

DementiaAlzheimer DiseaseVascular Dementia
Hopeful Aging120 enrolled1 locationNCT06298474
Recruiting
Not Applicable

Pulsed Electromagnetic Field Treatment With Dementia Patients

Alzheimer s DiseaseVascular DementiaLewy Body Dementia
Herrick Medical LLC48 enrolled1 locationNCT06862557
Recruiting
Not Applicable

ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing

Obstructive Sleep ApneaAlzheimer DiseaseDementia With Lewy Bodies+4 more
Sunnybrook Health Sciences Centre200 enrolled1 locationNCT04335994
Recruiting

The Swedish BioFINDER - Memory Clinic Study

Alzheimer DiseaseMild Cognitive ImpairmentLewy Body Disease+4 more
Skane University Hospital1,200 enrolled1 locationNCT06122415
Recruiting

The Swedish BioFINDER - Primary Care Study

Alzheimer DiseaseMild Cognitive ImpairmentLewy Body Disease+4 more
Skane University Hospital1,200 enrolled1 locationNCT06120361
Recruiting

Longitudinal Cognitive Assessment by BoCA

Multiple SclerosisAlzheimer DiseaseParkinson Disease+4 more
Alzheimer's Light LLC10,000 enrolled1 locationNCT04114994
Recruiting

China Cognition and Aging Study

Mild Cognitive Impairment (MCI)Alzheimer Disease, Late OnsetFamilial Alzheimer Disease (FAD)+3 more
Capital Medical University100,000 enrolled65 locationsNCT03653156
Recruiting

Cognitive Impairment in Ageing People

Cognitive ImpairmentAlzheimer DiseaseMCI+1 more
Yamei Tang5,000 enrolled1 locationNCT04360200